1.
Prevention and treatments for adverse drug reactions of oral small molecular targeting drugs
口服小分子靶向抗肿瘤药物的不良反应及防治措施
2.
Establishation of a Cellular Model to Screen for New Antitumor Drugs Targeting HIF-1;
靶向缺氧诱导因子HIF-1的抗肿瘤药物筛选的分子模型建立
3.
Exploration of Folate Receptor Mediated Antitumor Activity and Mechanism for Folate-macromolecular Conjugates;
叶酸高分子复合物靶向抗肿瘤药效及机理的探讨
4.
Clinical application of three kinds of antineoplastic target therapy drugs
新型抗肿瘤分子靶点药物临床应用分析
5.
EGFR-targeted agents in cancer therapy
靶向EGFR家族的抗肿瘤药物研究进展
6.
Study on Polymeric Micelles Targeting Delivery of Antitumor Agent;
高分子纳米胶束及其抗肿瘤药的靶向载药系统研究
7.
Design, Synthesis and Investigation of Bone Affinity of the Conjugate of 5-Fluorouracil and Hydroxybisphosphonate;
骨靶向抗肿瘤药物的设计，合成及亲骨性研究
8.
Antitumor Activity of a Novel DC-targeting Bifunctiona Fusion Protein;
靶向DC的双功能融合分子的抗肿瘤作用研究
9.
Investigation of Three Antineoplastic Targeted Drugs with High-frequency Clinic Application
3种用药频次较高的抗肿瘤靶向药物临床使用调研
10.
Evaluation on clinical application of 3 novel antineoplastic antibodies
3种新型抗肿瘤靶向抗体药物的临床应用状况评价
11.
Pharmaceutical Care of Clinical Pharmacist for a Cancer Patient Taking Molecular Targeted Drug:Sunitinib
临床药师对1例服用分子靶向药物舒尼替尼的肿瘤患者的药学监护
12.
Progress and Clinical Evaluation of Tumor-Targeted Therapy Drugs
肿瘤靶向治疗药物的进展与临床评价
13.
Experimental Study of Antitumor Activity of Targeted Drug Dilivery System for Folate-dextran-pirarubicin;
叶酸—葡聚糖—吡柔比星靶向药物的合成及抗肿瘤实验研究
14.
Experimental Study on Synthesis and Antitumor Activity of Targeted Drug Delivery System for Fluorouracil Using Sulfadiazine as the Carrier;
以磺胺嘧啶为载体的氟尿嘧啶靶向药物的合成及抗肿瘤实验研究
15.
Preparation of Chitosan-based Targeting Carriers and Their Conjugates with Antitumor Drugs;
基于壳聚糖的靶向载体的制备及其与抗肿瘤药物偶连的初步研究
16.
Establishment Models to Screen for New Antitumor Drugs Targeting Aurora A Kinase Inhibitors
靶向蛋白激酶Aurora A的抗肿瘤药物筛选模型的建立和评价
17.
Study on Brain Targeting Delivery Systems of Antineoplastic Drug Raltitrexed;
抗肿瘤药雷替曲塞的脑靶向给药系统研究
18.
Study on the Synthesis and Preliminary Target Tests of Conjugates of Methotrexate with Bisphosphonates as Bone-targeted Therapeutical Agents for Bone Tumors;
骨靶向抗肿瘤药物：甲氨蝶呤-偕二膦酸偶联物的合成及初步靶向性研究